B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells - Test2 - elhamkhani - TriplyDB

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

http://www.wikidata.org/entity/Q29620717

about

TCR-Engineered T Cells Meet New Challenges to Treat Solid Tumors: Choice of Antigen, T Cell Fitness, and Sensitization of Tumor Milieu Producer T cells: Using genetically engineered T cells as vehicles to generate and deliver therapeutics to tumors A Perspective of Immunotherapy for Prostate Cancer Clinical development of gene therapy: results and lessons from recent successes The role of blinatumomab in patients with relapsed/refractory acute lymphoblastic leukemia CAR models: next-generation CAR modifications for enhanced T-cell function CD19 chimeric antigen receptor (CD19 CAR)-redirected adoptive T-cell immunotherapy for the treatment of relapsed or refractory B-cell Non-Hodgkin's Lymphomas Natural Killer Cells for Immunotherapy - Advantages of the NK-92 Cell Line over Blood NK Cells Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects Chimeric Antigen Receptors Modified T-Cells for Cancer Therapy Adoptive T-cell therapies for refractory/relapsed leukemia and lymphoma: current strategies and recent advances A Perspective of Immunotherapy for Breast Cancer: Lessons Learned and Forward Directions for All Cancers Novel immunotherapies in lymphoid malignancies Therapeutic potential of CAR-T cell-derived exosomes: a cell-free modality for targeted cancer therapy Lymphoma Immunotherapy: Current Status Potentiality of immunotherapy against hepatocellular carcinoma Trial Watch: Adoptive cell transfer for oncological indications Adoptive immunotherapy for acute leukemia: New insights in chimeric antigen receptors Current practices and reform proposals for the regulation of advanced medicinal products in Canada Cord blood graft engineering CAR T Cell Therapy: A Game Changer in Cancer Treatment CAR T cells for solid tumors: armed and ready to go?T-cell and natural killer cell therapies for hematologic malignancies after hematopoietic stem cell transplantation: enhancing the graft-versus-leukemia effect Natural killer cell biology: an update and future directions CARs in chronic lymphocytic leukemia -- ready to drive Progress and prospects for engineered T cell therapies Genetically modified T cells for the treatment of malignant disease Immunotherapy advances for glioblastoma Novel immunotherapies for hematologic malignancies Adoptive T-cell therapy for Leukemia Toxicities of Immunotherapy for the Practitioner Immunotherapy in gastric cancer Clinical application of adoptive T cell therapy in solid tumors Using gene therapy to manipulate the immune system in the fight against B-cell leukemias Antibody, T-cell and dendritic cell immunotherapy for malignant brain tumors CD19 as an attractive target for antibody-based therapy Chimeric antigen receptor therapy for cancer CD4 T-cell immunotherapy for chronic viral infections and cancer Chimeric antigen receptor-engineered T cells for cancer immunotherapy: progress and challenges Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review

P2860

Q21131200-2DD01470-9D8A-4E20-8BF3-2349E29514CE Q26741260-8CB894DE-8ED7-403E-99C3-19A139F79577 Q26741277-62029849-6851-4D80-B053-D335C27216D8 Q26743393-0A85711D-716A-4436-B282-1138E85749BE Q26744280-C881CC7C-FE5D-4D3C-9ABF-27785C4B7660 Q26745600-A1F8993D-28FA-4BB0-B721-85C307777833 Q26749139-790707BB-A42E-4DA2-880F-6A2A52195B96 Q26751020-9C00768A-2475-492C-A47C-11FFA4AF9162 Q26753082-9A7A619D-A509-4230-9E11-D95B018449B2 Q26773309-20FCAF9F-C4D9-4EBC-860F-2676BFE3EBF8 Q26775720-DD32AE4A-C8FB-4B03-B0FF-0F000B446A27 Q26777111-170BFE62-4ADE-4D3A-B3B4-41693A03D26D Q26777394-D46CDA58-F011-4804-B1B0-89F90FE6B066 Q26779938-FF7B0282-E04B-4345-9F94-479D3BBCB11E Q26782902-1BF127C3-5404-4C09-B808-846A2790CED9 Q26784228-BBFE1B35-D024-43D8-87E5-D0595534BA14 Q26785545-012A0FBA-4FCE-4F29-ACDA-D741109467C3 Q26795540-D7D7CE33-F32C-4B62-8443-213DC31C0644 Q26799720-35FCCCFC-584A-44AF-B00D-0A3E739BA43D Q26822376-5D098B11-6AF8-4AF1-AAF4-AC05A8D67446 Q26822769-49F63ED3-CA38-48C7-BA94-9221192146F2 Q26825489-A21C55FC-1C8B-41BB-BC33-8BB1C433FD07 Q26826830-DC5C2CDC-5AC4-4339-B6FE-00438BFAA921 Q26830512-44DF7909-5885-4162-84F3-D82E40CF4B32 Q26830526-D5A70BFD-D7B2-4433-A3C8-97A83B6ECAEA Q26852923-6702F204-DC9B-4D76-A082-A7A4B8AECDD1 Q26860657-1CDDF255-2B8E-4CA9-A519-8187EC9509D2 Q26866513-AA650D8B-9808-4B13-A3FB-A9E073401840 Q27004436-B9684EB1-E5EE-484C-AB83-766F1D2F2539 Q27006934-FAF728E1-2BC1-4C51-AC0A-DF379A9B980A Q27008140-B86D3C97-8B48-414D-B3FA-DC22F7EB1584 Q27010472-36F25888-97CA-4B7B-8DC4-2C0AE3A66A57 Q27011283-4CBAD6A5-D04C-4EDB-B57E-494AB9690F4D Q27011297-91FD5765-CA38-4923-B35B-9A8BA6B28A5E Q27011298-0577D904-4E78-4427-8A48-499BCC5A5C3E Q27011836-4B80A526-CBCC-4B05-BABF-52A732FAB864 Q27013599-BF6A8732-D918-40E9-9080-EA66FDA3EFB7 Q27022957-AD3273B4-1506-4BC7-8609-D99D198C0E65 Q27025300-EA7F2C9A-C8A1-4F1E-9C77-C260D041755E Q27304386-083AD99F-9AA5-4898-9A86-408769C9DDF9

P2860

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

http://www.wikidata.org/entity/Q29620717

description

2012 nî lūn-bûn

@nan

2012 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մարտին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

B-cell depletion and remission ...... en-receptor-transduced T cells

@ast

B-cell depletion and remission ...... en-receptor-transduced T cells

@en

type

label

B-cell depletion and remission ...... en-receptor-transduced T cells

@ast

B-cell depletion and remission ...... en-receptor-transduced T cells

@en

prefLabel

B-cell depletion and remission ...... en-receptor-transduced T cells

@ast

B-cell depletion and remission ...... en-receptor-transduced T cells

@en

P1433

Q29620717-E1119F5A-1830-48FB-AE1E-954F68B654BF

P1476

Q29620717-BDC6DD6B-BAF6-4778-A86F-130BE0A628D2

P2093

Q29620717-1091F00C-A0F1-4A43-AE6C-A7D8DD28B09A

Q29620717-1669E1A6-9616-4D23-BDFE-7DA666C896F5

Q29620717-26E261E8-A7A0-46AC-A9D9-66D91AA3E93B

Q29620717-2E6D1B69-BE89-4DA5-A8F6-807B78965910

Q29620717-43B71F4C-9F9B-4F97-A6CE-1B2739818E64

Q29620717-4B265BE4-0F2A-46BD-9115-4BC29686EAC5

Q29620717-6846FEB2-780F-4096-AD97-2BE035666B49

Q29620717-80839C81-86EE-4734-94F9-AFEAA89AA33E

Q29620717-9395DDC7-E766-4654-8521-8C88B11C99DE

Q29620717-9FCBF0E0-81F1-4CB4-B630-FAE0BF71689A

P2860

Q29620717-00514276-BF39-44FE-9B95-F91C9B7D0C5E

Q29620717-0286937C-C6AB-4ABB-81F3-89179E206240

Q29620717-09041704-4D1A-439E-9FC8-A4587C54F997

Q29620717-0994D3A5-DE14-46D6-81F1-C1CD10463743

Q29620717-1CA71802-52AA-4812-AF40-1DD2A83FFD4E

Q29620717-1DDAA447-9557-4DBF-8E0C-A6B66BDB7937

Q29620717-26975776-8771-4DDA-9A81-E481B0B309E3

Q29620717-2F89D19D-1778-4C00-851C-8AAE936AC90C

Q29620717-331BC23F-82EF-43FA-AACE-B69FD360F34E

Q29620717-415A7DF7-B746-4006-AB2A-B940A5E14485

P304

Q29620717-7D10A47E-EA2C-481D-84D3-C1DA791A8DAC

P31

Q29620717-7578AD52-0BF3-40D9-9DB1-5E12BDA57A2A

Q29620717-9E02F854-8A68-4F5F-9D5C-91EE0362259C

P3181

Q29620717-843A9DB4-F4D2-487C-BFC2-94E80F4E51FF

P356

Q29620717-A01A0904-6253-4F33-970E-5AB113E44AED

P407

Q29620717-D7CD45CC-3FD5-4097-A765-E75A6263E48D

P433

Q29620717-3AB610AC-DBA3-483D-BD85-10E9B6BA47A6

P478

Q29620717-7E2A3FD3-6FC5-4D49-B99F-3A3650E6CF00

P577

Q29620717-A727377A-9240-4535-87B1-56C6437E8AAB

P5875

Q29620717-78D32DB4-734A-429A-A8FF-1694A87B3181

P698

Q29620717-212AAEE9-23A4-47AA-9139-829E93E6ECEB

P932

Q29620717-D3C61A8E-68BE-44C5-8116-F84A6077FFBD

P3181

P356

BLOOD-2011-10-384388

P1433

P1476

B-cell depletion and remission ...... en-receptor-transduced T cells

@en

P2093

Carpenter R

http://www.w3.org/2001/XMLSchema#string

Devillier L

http://www.w3.org/2001/XMLSchema#string

Dudley ME

http://www.w3.org/2001/XMLSchema#string

Feldman SA

http://www.w3.org/2001/XMLSchema#string

Hughes MS

http://www.w3.org/2001/XMLSchema#string

Kammula US

http://www.w3.org/2001/XMLSchema#string

Kochenderfer JN

http://www.w3.org/2001/XMLSchema#string

Laurencot C

http://www.w3.org/2001/XMLSchema#string

Maric I

http://www.w3.org/2001/XMLSchema#string

Morgan RA

http://www.w3.org/2001/XMLSchema#string

P2860

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen

T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia

Serial evaluation of the SOFA score to predict outcome in critically ill patients

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

Antibody-mediated B-cell depletion before adoptive immunotherapy with T cells expressing CD20-specific chimeric T-cell receptors facilitates eradication of leukemia in immunocompetent mice.

P304

2709-20

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1288227

http://www.w3.org/2001/XMLSchema#string

P356

10.1182/BLOOD-2011-10-384388

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51870246

http://www.w3.org/2001/XMLSchema#string

P698

22160384

http://www.w3.org/2001/XMLSchema#string

P932

3327450

http://www.w3.org/2001/XMLSchema#string